Beyond Vaccine Availability: Community Trust and Human Papillomavirus Vaccine Acceptance in Sub-Saharan Africa: A Narrative Review
Abstract
Even though most cases of cervical cancer are preventable with human papillomavirus (HPV) vaccines, cervical cancer continues to be a public health problem in sub-Saharan Africa. HPV vaccines have long been available, but vaccine coverage remains far below the global goal in the region. However, structural barriers contribute to this disparity, and they cannot fully explain a community's occasional failure to accept vaccines. This narrative review explored community trust as a determinant of HPV vaccine acceptance in sub-Saharan Africa. It examined evidence identified from PubMed, Scopus, Google Scholar, Web of Science, and the World Health Organisation (WHO) Institutional Repository. The literature search (May to July 2026) yielded around 180 records, of which 36 were included in the synthesis. All studies reviewed found strong community trust to underlie other factors that influence vaccine uptake. Where trust was lower, gaps in knowledge, misinformation, healthcare worker recommendations, attitudes of traditional and religious leaders, and family decisions had a greater impact; the opposite was true with heightened trust. This pattern was found in various contexts in Rwanda, Tanzania, Nigeria, Kenya, Uganda and Malawi. The results here indicate that simply bolstering HPV vaccine supply and service delivery is not enough. Ongoing, meaningful engagement to build and maintain community trust should be considered an essential element of HPV vaccination programmes in sub-Saharan Africa.
Keywords
Full Text:
PDFReferences
1. World Health Organisation. (2026, July 3). Cervical cancer. Retrieved from https://www.who.int/news-room/fact-sheets/detail/cervical-cancer
2. International Agency for Research on Cancer. (2024). Cancer today: Nigeria. Retrieved from https://gco.iarc.who.int/media/globocan/factsheets/populations/566-nigeria-fact-sheet.pdf
3. World Health Organisation. (2020, November 17). Global strategy to accelerate the elimination of cervical cancer as a public health problem. Retrieved from https://www.who.int/publications/i/item/9789240014107
4. Kutz, J.-M., Rausche, P., Gheit, T., Puradiredja, D. I., & Fusco, D. (2023). Barriers and facilitators of HPV vaccination in sub-saharan Africa: a systematic review. BMC Public Health, 23(1). doi: 10.1186/s12889-023-15842-1
5. Acheampong, T., Akorsikumah, E. A., Osae-Kwapong, J., Khalid, M., Appiah, A., & Amuasi, J. H. (2021). Examining Vaccine Hesitancy in Sub-Saharan Africa: A Survey of the Knowledge and Attitudes among Adults to Receive COVID-19 Vaccines in Ghana. Vaccines, 9(8), 814. doi: 10.3390/vaccines9080814
6. Yusuf, K. K., Olorunsaiye, C. Z., Gadanya, M. A., Ouedraogo, S., Abdullahi, A. A., & Salihu, H. M. (2024). HPV vaccine hesitancy among parents and caregivers of adolescents in Northern Nigeria. Vaccine: X, 21, 100591. doi: 10.1016/j.jvacx.2024.100591
7. Kubura, D., Sampson, S., Erekosima, G., Dauda, M., Atobatele, S., Oni, M., Samuel, O., Ngobua, S., Akpen, C., Popoola, G., Okoh, C., Mukhtar, A.-M., Nnaji, K., Nzeribe, E., Ukoh, H., Agunbiade, I., Mohammed, F., & Okagbue, H. (2025). Stakeholders' perspectives on lessons learnt from HPV mass vaccination in Nigeria. BMC Public Health, 25(1). doi: 10.1186/s12889-025-24418-0
8. Agha, S., & Nsofor, I. (2025). HPV vaccine uptake among adolescent girls in Nigeria: The complex role of caregivers' education. PLOS One, 20(7), e0325684. doi: 10.1371/journal.pone.0325684
9. Bwanali, A. N., Liundi, P., Lubanga, A. F., Mpinganjira, S. L., & Gadama, L. A. (2024). Caregiver acceptance of human papillomavirus vaccine for their female children in Chileka, Blantyre, Malawi. Vaccine: X, 20, 100557. doi: 10.1016/j.jvacx.2024.100557
10. Ochomo, E. O., Tonui, P., Muthoka, K., Amboka, S., Itsura, P., Omenge Orang’o, E., Rosen, B., Loehrer, P., & Cu-Uvin, S. (2024). Addressing HPV vaccine hesitancy: unveiling concerns and building trust' perspectives of adolescent girls and parents in Kisumu County, Kenya. Ecancermedicalscience, 18. doi: 10.3332/ecancer.2024.1735
11. Deignan, C., Swartz, A., Cooper, S., & Colvin, C. J. (2021). Stakeholders' Understandings of Human Papillomavirus (HPV) Vaccination in Sub-Saharan Africa: A Rapid Qualitative Systematic Review. Vaccines, 9(5), 496. doi: 10.3390/vaccines9050496
12. Paterson, P., Meurice, F., Stanberry, L. R., Glismann, S., Rosenthal, S. L., & Larson, H. J. (2016). Vaccine hesitancy and healthcare providers. Vaccine, 34(52), 6700–6706. doi: 10.1016/j.vaccine.2016.10.042
13. WHO Regional Office for Africa. (2024, September 9). Government, partners and northern traditional leaders reaffirm commitment to Nigeria's immunisation and health services goals. Retrieved from https://www.afro.who.int/countries/nigeria/news/government-partners-and-northern-traditional-leaders-reaffirm-commitment-nigerias-immunisation-and
14. Bolaji, A. (2024, June 11). Nigeria's Kwara State rolls out HPV vaccine to enthusiastic reception. Retrieved from https://www.gavi.org/vaccineswork/kwara-state-rolls-out-hpv-vaccine-enthusiastic-reception
15. Adupong, R. (2025, March 11). The Nigerian cleric on a mission to protect girls from cervical cancer. Retrieved from https://www.gavi.org/vaccineswork/clerics-mission-protect-girls-northern-nigeria-cervical-cancer
16. Okenyoru, D. S., Kaaria, F., Odhiambo, F. B., Murugi, L., Matoke, V. O., Salima, R., Anyika, D., Ogutu, G., & Musau, A. (2024). Religious leaders' willingness to promote the uptake of human papillomavirus vaccine among their congregants in Mavoko Sub-County, Machakos County, Kenya. The Pan African Medical Journal, 48. doi: 10.11604/pamj.2024.48.141.43492
17. Burgess, R. A., Osborne, R. H., Yongabi, K. A., Greenhalgh, T., Gurdasani, D., Kang, G., Falade, A. G., Odone, A., Busse, R., Martin-Moreno, J. M., Reicher, S., & McKee, M. (2021). The COVID-19 vaccines rush: participatory community engagement matters more than ever. The Lancet, 397(10268), 8–10. doi: 10.1016/s0140-6736(20)32642-8
18. UNICEF. (2024, September 19). Generations unite in Nigeria's HPV vaccine campaign. Retrieved from https://www.unicef.org/stories/generations-unite-nigerias-hpv-vaccine-campaign
19. Asempah, E., & Wiktorowicz, M. E. (2023). Understanding HPV Vaccination Policymaking in Rwanda: A Case of Health Prioritization and Public-Private-Partnership in a Low-Resource Setting. International Journal of Environmental Research and Public Health, 20(21), 6998. doi: 10.3390/ijerph20216998
20. Carlton, J. G., Pamba, D., Ryan, N., Olomi, W., Ntinginya, N. E., Tinuga, F., Maganga, L., William, W., Lwilla, A., Kapesa, E., Mwakisisile, J., Magesa, D., Mbunda, A., Grund, J. M., McCormick, L. J., Hyde, T., & Casey, R. (2025). Facilitators and barriers to implementation of HPV vaccination in Tanzania: a mixed-methods study exploring perspectives from national, subnational, and community stakeholders, 2018–2023. Vaccine, 62, 127560. doi: 10.1016/j.vaccine.2025.127560
21. Tuhebwe, D., Adyedo, C., Ahumuza, E., Ssendagire, S., & Wanyenze, R. K. (2024). Improving HPV vaccine acceptance through peer-to-peer education among adolescent girls in the urban poor settings of Kisenyi, Kampala, Uganda. PLOS Global Public Health, 4(12), e0004007. doi: 10.1371/journal.pgph.0004007
22. MacDonald, N. E. (2015). Vaccine hesitancy: Definition, scope and determinants. Vaccine, 33(34), 4161–4164. doi: 10.1016/j.vaccine.2015.04.036
23. Stoop, N., Hirvonen, K., & Maystadt, J.-F. (2021). Institutional mistrust and child vaccination coverage in Africa. BMJ Global Health, 6(4), e004595. doi: 10.1136/bmjgh-2020-004595
24. Bhengu, P., Wiysonge, C. S., Katoto, P. D. M. C., Ndwandwe, D., Cooper, S., Bhengu, S., Mazingisa, A. V., Saber, T., Sithole, M., Smith, D., Tembe, L. G., Kuodi, P., & Shey, M. S. (2025). Factors Associated with Acceptance of Vaccination Against Human Papillomavirus in eThekwini District of South Africa. Vaccines, 13(7), 732. doi: 10.3390/vaccines13070732
25. Adams, R. A., Visser, C., Dreyer, G., Snyman, L., van der Merwe, F. H., & Botha, M. H. (2024). Sociodemographics, behaviour and knowledge of first South African HPV-vaccine recipients. South African Family Practice, 66(1). doi: 10.4102/safp.v66i1.5913
26. Asempah, E., Ikpebe, E., Wyndham-West, M., & Wiktorowicz, M. E. (2025). Challenges and Opportunities for Cervical Cancer Prevention Through HPV Vaccination in Ghana: A Public Health Policy Analysis. Cancer Control, 32. doi: 10.1177/10732748251383280
27. John, A., Abbah, A. P., & Sandøy, I. F. (2025). Associations of socioeconomic factors with parents' awareness and acceptability of HPV vaccination in sub-Saharan Africa - a systematic review and meta-analysis. BMC Public Health, 25(1). doi: 10.1186/s12889-025-24550-x
28. Adeyanju, G. C., Essoh, T.-A., Sidibe, A. R., Kyesi, F., & Aina, M. (2024). Human Papillomavirus Vaccination Acceleration and Introduction in Sub-Saharan Africa: A Multi-Country Cohort Analysis. Vaccines, 12(5), 489. doi: 10.3390/vaccines12050489
29. World Health Organization. (2022). Human papillomavirus vaccines: WHO position paper, December 2022. Weekly Epidemiological Record, 97(50), 645–672.
30. Scheepers, V. C., & Jillian. (2025). Expanding the case for gender-neutral human papillomavirus vaccination in South Africa: Emerging neonatal and ethical considerations. African Journal of Primary Health Care & Family Medicine, 17(1). doi: 10.4102/phcfm.v17i1.5035
31. Azale, T., Alemayehu, T., Belay, H. T., Oot, L., Gebeyehu, A., Temesgen, Z., Tamir, T., Mulat, L., Ayalew, M., Bogale, M., & Wondwossen, L. (2026). Bridging the Gap: Disparities in HPV Vaccine Uptake Between In-School and Out-of-School Girls Following a Demand Generation Intervention in Ethiopia: A Cross-Sectional Study. Vaccines, 14(5), 405. doi: 10.3390/vaccines14050405
32. Enyew, E. B., Kasaye, M. D., Kebede, S. D., Feyisa, M. S., Serbessa, N. G., Tebeje, T. M., & Tareke, A. A. (2025). Human Papillomavirus Vaccination uptake and associated factors among schools girls aged between 9–14 years in Ethiopia: Performance Monitoring for Action (PMA-ET) 2023, multilevel analysis. PLOS One, 20(6), e0325557. doi: 10.1371/journal.pone.0325557
33. Dera, M., Wondimagegnehu, A., & Asfaw, Z. G. (2023). Determinants for hesitancy in human papillomavirus (HPV) vaccine uptake among school girls in Jimma Town, Ethiopia. A mixed approach: quantitative and qualitative. Reproductive Health, 20(1). doi: 10.1186/s12978-023-01711-y
34. Machalek, D. A., Nyemba, D. C., Travill, D., Petoumenos, K., Mbulawa, Z. Z. A., Naidoo, I., Motshwane, F. M. M., Bamford, L., Rees, H., Kaldor, J. M., Delany-Moretlwe, S., Chikandiwa, A., Makae, M., Mzimela, T., Mogodiri, T., Ndlovu, N., Mkwanazi, E., Munthali, R., Brotherton, J. M., et al. (2026). Population impact of South Africa's human papillomavirus (HPV) vaccination programme on HPV prevalence in adolescent girls with and without HIV: a repeat cross-sectional study. The Lancet Global Health, 14(4), e570–e578. doi: 10.1016/s2214-109x(25)00525-x
35. Mwaba, D. K., Khondowe, S., Daka, V., Mwanza, P., Chisanga, C., Kalasa, H., & Nambozi, M. (2024). Human Papilloma Virus Vaccine Acceptability and Its Associated Factors among Mothers of Female Children 9-14 Years in Ndola District of Zambia. Open Journal of Obstetrics and Gynecology, 14(11), 1757–1774. doi: 10.4236/ojog.2024.1411145
36. Lubeya, M. K., Chibwesha, C. J., Mwanahamuntu, M., Mukosha, M., Frank, S., & Kawonga, M. (2023). "When you get the HPV vaccine, it will prevent cervical cancer; it will act as a shield": adolescent girls' knowledge and perceptions regarding the human papillomavirus vaccine in Zambia. Frontiers in Health Services, 3. doi: 10.3389/frhs.2023.1208458
37. Lubeya, M. K., Mwanahamuntu, M., Chibwesha, C. J., Mukosha, M., & Kawonga, M. (2024). Selecting and Tailoring Implementation Strategies to Improve Human Papillomavirus Vaccine Uptake in Zambia: A Nominal Group Technique Approach. Vaccines, 12(5), 542. doi: 10.3390/vaccines12050542
38. Johm, P., Jallow, M. M., Manneh, E., & Clarke, E. (2025). Primary caregivers' acceptance of gendered human papillomavirus (HPV) vaccination across The Gambia. Vaccine: X, 27, 100755. doi: 10.1016/j.jvacx.2025.100755
39. Amuzie, C. I., Bassi, A. P., Fishman, E., Mekonnen, D., Rogers-Bloch, Q., Cappelier, K., LaMontagne, S., Kalu, K. U., Izuka, M., & Sunday, S. T. (2025). Parental acceptance of human papillomavirus vaccine for female adolescents in Abia State, southeastern Nigeria: a pre-implementation study. Pan African Medical Journal, 51. doi: 10.11604/pamj.2025.51.44.43317
40. Njoh, A. A., Bolio, A., Venczel, L., Libwea, J. N., Waheed, D.-e.-N., Kongnyuy, E. J., Amani, A., Saidu, Y., Dinga, J. N., Ngenge, B. M., Mbanga, C., Madaina, I., Abizou, M. B., & Cleenewerck de Kiev, L. (2026). Key players and determinants improving human papillomavirus vaccination coverage in Cameroon: a cross-sectional nationwide health workers survey. Vaccine, 69, 128006. doi: 10.1016/j.vaccine.2025.128006
Article Metrics
Metrics powered by PLOS ALM
Refbacks
- There are currently no refbacks.
Copyright (c) 2026 Olamide Peter Olaobaju, Jennifer Abrahan, Taiwo Bakare-Abidola, Kehinde Abiola Bakare-Adesokan
This work is licensed under a Creative Commons Attribution 4.0 International License.
Email the author